Cited by 40Animal testing and alternativesCarcinogens and Genotoxicity AssessmentImmunotoxicology and immune responses

Use and validation of HT/HC assays to support 21st century toxicity evaluations

Open access
Patlewicz, Grace, Simon, Ted, Goyak, Katy, Phillips, Richard D., Rowlands, J. Craig, Seidel, Shawn D., Becker, Richard A.·2013·Regulatory Toxicology and Pharmacology

Abstract

Advances in high throughput and high content (HT/HC) methods such as those used in the fields of toxicogenomics, bioinformatics, and computational toxicology have the potential to improve both the efficiency and effectiveness of toxicity evaluations and risk assessments. However, prior to use, scientific confidence in these methods should be formally established. Traditional validation approaches that define relevance, reliability, sensitivity and specificity may not be readily applicable. HT/HC methods are not exact replacements for in vivo testing, and although run individually, these assays are likely to be used as a group or battery for decision making and use robotics, which may be unique in each laboratory setting. Building on the frameworks developed in the 2010 Institute of Medicine Report on Biomarkers and the OECD 2007 Report on (Q)SAR Validation, we present constructs that can be adapted to address the validation challenges of HT/HC methods. These are flexible, transparent, and require explicit specification of context and purpose of use such that scientific confidence (validation) can be defined to meet different regulatory applications. Using these constructs, we discuss how anchoring the assays and their prediction models to Adverse Outcome Pathways (AOPs) could facilitate the interpretation of results and support scientifically defensible fit-for-purpose applications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.yrtph.2012.12.008

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mechanistic validation may provide a measure of test method performance even when a good reference dataset is not available.

    “Such an approach may provide a measure of test method performance, even when a good reference dataset is not available (Leist et al., 2012; Patlewicz et al., 2013; Patterson et al., 2021; Tigges et al., 2021).”

    From Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibility (2024) · cites this paper as Patlewicz et al., 2013

    Section 4 says mechanistic relevance provides a biological anchor for an assay, while analytical validation assesses its performance. Section 3.1 proposes assessing performance with a set of reference chemicals; it does not say that mechanistic validation measures performance when a good reference dataset is unavailable. Page numbers are not available in our copy. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. European Chemicals Agency, 2008. Guidance on information requirements and chemical safety assessment (Chapter R6).
  2. Organization for Economic Co-operation and Development (OECD), 2007. Guidance document on the validation of (Quantitative) structure-activity relationships [(Q)SAR] models at http://www.oecd.org/officialdocuments/displaydocument- pdf?cote=env/jm/mono(2007)2&doclanguage=en (accessed 30.03.2012). Organization for Economic Co-operation and Development (OECD), 2011. Series on testing and assessment No. 138. Report of the workshop on using mechanistic information in forming chemical categories. ENV/JM/MONO(2011) 8.
  3. United States Environmental Protection Agency (USEPA), 2007. Framework for Determining a Mutagenic Mode of Action for Carcinogenicity. EPA 120/R-07/ 002-A. External Review Draft. September 2007.

Cited by

Sorted by citations

Authors
Patlewicz, G., Simon, T., Goyak, K., Phillips, R. D., Rowlands, J. C., Seidel, S. D., & Becker, R. A.
Affiliations
  • DuPont (United States) (US)
  • ExxonMobil (United States) (US)
  • Dow Chemical (United States) (US)
  • American Chemistry Council (US)
Corresponding author
Patlewicz, Grace
Venue
Regulatory Toxicology and Pharmacology
Publisher
Elsevier BV
Published
2013-03
Volume
65
Issue
2
Pages
259-268
ISSN
0273-2300 (ISSN-L)
OpenAlex
W1988231503
Cited by
40
References
38
Citations by year
2025: 3 · 2024: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 7 · 2015: 9 · 2014: 6 · 2013: 1
FWCI
10.79
Type
journal article
Language
en
Open access
Locations
  • Regulatory Toxicology and Pharmacology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
Keywords
high-throughput screening, high-content screening, assay validation, toxicity prediction, adverse outcome pathways, fit for purpose, computational toxicology, toxicogenomics, biomarkers, QSAR validation, risk assessment, scientific confidence
MeSH terms
Animals, Animal Testing Alternatives, Humans, Xenobiotics, Risk Assessment, Toxicity Tests, High-Throughput Screening Assays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review